| Hitesh R Amin, PHARMACIST | |
|
Sav-on Pharmacy, 1008 Nevada Way, Boulder City, NV 89005 | |
| (702) 293-7592 | |
| (702) 293-7606 |
| Full Name | Hitesh R Amin |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | Sav-on Pharmacy, Boulder City, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336763119 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12279 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hitesh R Amin, PHARMACIST 7697 White Ginger Ave, Las Vegas, NV 89178-8403 Ph: (702) 439-3470 | Hitesh R Amin, PHARMACIST Sav-on Pharmacy, 1008 Nevada Way, Boulder City, NV 89005 Ph: (702) 293-7592 |
News Archive
Monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance, called expectant management, is a useful approach for a large number of men with localized tumors and could spare them the debilitating side effects of aggressive treatments that are too often unnecessarily used in this patient population, a UCLA review of common practices in prostate cancer has found.
A new study presented today at the International Liver Congress- 2012 demonstrates that the gut microbiota has a profound systemic effect on bile acid metabolism.
Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
› Verified 6 days ago
Sheryl Rose, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1031 Nevada Hwy, Boulder City, NV 89005 Phone: 702-293-6347 Fax: 702-293-6274 | |
Mrs. Sharlene Ann Mcneil Philpott, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1031 Nevada Hwy, Boulder City, NV 89005 Phone: 702-293-6347 Fax: 702-293-6274 | |
Mark Melgaard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1017 Nevada Way, Boulder City, NV 89005 Phone: 702-293-6705 | |
Mr. John Revolinski, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1521 Mancha Dr, Boulder City, NV 89005 Phone: 213-300-2438 | |
Ashlie Simon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1017 Nevada Way, Boulder City, NV 89005 Phone: 702-293-6705 | |
Ramona Kristina Sirgedas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 643 Florence Dr, Boulder City, NV 89005 Phone: 702-994-9012 |